A Clinical trial to study the effect of the drug Guru Parpam in the management of the patients having Polyarthritis(Santhu vatham)
Phase 2
Not yet recruiting
- Conditions
- Rheumatoid arthritis without rheumatoid factor,
- Registration Number
- CTRI/2021/11/037714
- Lead Sponsor
- Government SIddha Medical College
- Brief Summary
This is a Single non randomised open clinical trial to study the safety and efficacy of siddha trial drug Guru Parpam.The Trial is given 488mg twicea day for 48 days. Clinical trial conducted after conducting Pre-clinical toxicity study. The trial drug Guru parpam is mentioned in Sarabendra vaidiya rathnavali .During the trial all the study related data will be recorded and documented. After the completion of the trial all the data will be analysed statistically.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Joint pain Swelling Stiffness Tenderness Restricted movements Post viral arthritis Seronegative RA.
Exclusion Criteria
Pregnancy and lactating women Rheumatic fever Rheumatoid arthritis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary Outcome is mainly assessed by reduction in clinical symptoms measured by universal pain assessment scale 48 days
- Secondary Outcome Measures
Name Time Method Secondary Outcome is mainly assessed by comparing the safety parameters before and after treatment 48 days
Trial Locations
- Locations (1)
Aringar Anna Government Hospital of Indian Medicine
🇮🇳Chennai, TAMIL NADU, India
Aringar Anna Government Hospital of Indian Medicine🇮🇳Chennai, TAMIL NADU, IndiaDr Pavithra KPrincipal investigator9944972987pavithrakannadasan222@gmail.com